Join
Live feed
·
PRReleasevia Quantisnow
Simulations Plus Inc. logo

Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities

ByQuantisnow·Wall Street's wire, on your screen.
SLP· Simulations Plus Inc.
Technology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLP (Simulations Plus Inc.) and more on Quantisnow.